Michael Mullette is an experienced drug development and commercialization expert, currently serving as Chief Operating Officer at Lykos Therapeutics Inc (formerly MAPS PBC). Mullette most recently served as the Vice President and Managing Director of North America for Moderna, where he oversaw commercialization of the company’s COVID-19 vaccine during the height of the pandemic.
